Helicos BioSciences (HLCS) announced it has entered into a scientific collaboration with the Children's Oncology Group in order to interrogate a wide spectrum of genomic variation within various sarcomas, an aggressive type of bone or soft tissue cancer usually found in children and young adults.
The collaboration is aimed at demonstrating the power and versatility of the Helicos True Single Molecule Sequencing technology to measure the DNA sequence, methylation state, and mRNA expression levels of normal, primary and metastatic cell states.
For comments and feedback: editorial@rttnews.com